We studied the effect of transforming growth factor (TGF)–β on immortalized human vocal fold fibroblasts.
Methods:
Normal human vocal fold fibroblasts were subjected to sequential lentiviral transduction with genes for human telomerase (hTERT) and SV40 large T antigen in order to produce an “immortalized” cell line of normal phenotype. After confirmation of vocal fold fibroblast transfection, these cells, referred to as HVOX, were treated with various concentrations of exogenous TGF-β1 and assayed for collagen secretion, migration, and proliferation. In addition, components of the TGF-β signaling pathway were examined in this cell line.
Results:
TGF-β stimulated collagen secretion and migration without altering proliferation of HVOX. HVOX constitutively expressed type I and II TGF-β receptors, as well as messenger RNA for the Smad signaling proteins and for all TGF-β isoforms. Exogenous TGF-β1 induced temporally dependent alterations in Smad2 and Smad3 gene expression. TGF-β increased Smad7 expression at both 4 and 24 hours. Prolonged exposure to TGF-β decreased TGF-β1 gene expression.
Conclusions:
Insight into the underlying pathophysiology of vocal fold fibrosis is likely to yield improved therapeutic strategies to mitigate vocal fold scarring. Our data suggest that TGF-β signaling may be both paracrine and autocrine in this vocal fold fibroblast cell line, and we therefore propose that TGF-β may be a reasonable target for therapies to prevent and/or treat vocal fold fibrosis, given its putative role in both acute and chronic vocal fold injury, as well as its effects on vocal fold fibroblasts.
BorderWANobleNA. Transforming growth factor beta in tissue fibrosis. N Engl J Med1994;331:1286–92.
9.
JonssonJRCloustonADAndoY. Angiotensinconverting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology2001;121:148–55.
10.
DufloSMThibeaultSLLiWSmithMESchadeGHessMM. Differential gene expression profiling of vocal fold polyps and Reinke's edema by complementary DNA microarray. Ann Otol Rhinol Laryngol2006;115:703–14.
11.
LimXTateyaITateyaTMuñoz-Del-RioABlessDM. Immediate inflammatory response and scar formation in wounded vocal folds. Ann Otol Rhinol Laryngol2006;115:921–9.
12.
HiranoSBlessDHeiseyDFordC. Roles of hepatocyte growth factor and transforming growth factor β1 in production of extracellular matrix by canine vocal fold fibroblasts. Laryngoscope2003;113:144–8.
13.
HiranoSBlessDMHeiseyDFordCN. Effect of growth factors on hyaluronan production by canine vocal fold fibroblasts. Ann Otol Rhinol Laryngol2003;112:617–24.
14.
HiranoSBlessDMMasseyRJHartigGKFordCN. Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor. Ann Otol Rhinol Laryngol2003;112:1026–33.
15.
HiranoSBlessDMNagaiH. Growth factor therapy for vocal fold scarring in a canine model. Ann Otol Rhinol Laryngol2004;113:777–85.
16.
HiranoSBlessDMRousseauB. Prevention of vocal fold scarring by topical injection of hepatocyte growth factor in a rabbit model. Laryngoscope2004;114:548–56.
17.
KitaharaSMasudaYKitagawaY. Vocal fold injury following endotracheal intubation. J Laryngol Otol2005;119:825–7.
18.
DingHGraySD. Senescent expression of genes coding collagens, collagen degrading metalloproteinases, and tissue inhibitors of metalloproteinases in rat vocal folds: Comparison with skin and lungs. J Gerontol A Biol Sci Med Sci2001;56:B145–B152.
19.
DingHGraySD. Senescent expression of genes coding tropoelastin, elastase, lysyl oxidase, and tissue inhibitors of metalloproteinases in rat vocal folds: Comparison with skin and lungs. J Speech Lang Hear Res2001;44:317–26.
20.
ThibeaultSLLiWGraySDChenZ. Instability of extracellular matrix gene expression in primary cell culture fibroblasts from human vocal fold lamina propria and tracheal scar. Ann Otol Rhinol Laryngol2002;111:8–14.
21.
YlitaloRBaughALiWThibeaultS. Effect of acid and pepsin on gene expression in laryngeal fibroblasts. Ann Otol Rhinol Laryngol2004;113:866–71.
22.
LundbergASRandellSHStewartSA. Immortalization and transformation of primary airway epithelial cells by gene transfer. Oncogene2002;21:4577–86.
23.
DaviesBRSteeleIAEdmondsonRJ. Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen. Exp Cell Res2003;288:390–402.
24.
KudoYHiraokaMKitagawaS. Establishment of human cementifying fibroma cell lines by transfection with temperature-sensitive simian virus–40 T-antigen gene and hTERT gene. Bone2002;30:712–7.
25.
WekslerBBSubileauEAPerrièreN. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J2005;19:1872–4.
26.
ZennouVSergueraCSarkisC. The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol2001;19:446–50.
27.
SirvenARavetECharneauP. Enhanced transgene expression in cord blood CD34(+)derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol Ther2001;3:438–8.
28.
GianniniCMorosanSTralhaoJG. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology2003;38:114–22.
29.
BuchetDSergueraCZennouVCharneauPMalletJ. Long-term expression of beta-glucuronidase by genetically modified human neural progenitor cells grafted into the mouse central nervous system. Mol Cell Neurosci2002;19:389–401.
30.
KellnerDChenJRichardsonI. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol2006;176:806–12.
31.
SandulacheVCDoharJEHebdaPA. Adult-fetal fibroblast interactions: Effects on cell migration and implications for cell transplantation. Cell Transplant2005;14:331–7.
32.
El ChaarMChenJSeshanSV. Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction. Am J Physiol Renal Physiol2007;292:F1291–F1301.
33.
BranskiRCRosenCAVerdoliniKHebdaPA. Acute vocal fold wound healing in a rabbit model. Ann Otol Rhinol Laryngol2005;114:19–24.
34.
ThibeaultSLGraySDBlessDMChanRWFordCN. Histologic and rheologic characterization of vocal fold scarring. J Voice2002;16:96–104.
35.
LiuXHuHYinJQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int2006;26:8–22.
36.
SandulacheVCParekhALi-KorotkyHSDoharJEHebdaPA. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: Implication for wound healing. Wound Repair Regen2006;14:633–43.
37.
Strick-MarchandMMorosanSCharneauPKremsdorfDWeissMC. Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci U S A2004;101:8360–5.
38.
MordeletEKissaKCalvoCF. Brain engraftment of autologous macrophages transduced with a lentiviral flap vector: An approach to complement brain dysfunctions. Gene Ther2002;9:46–52.
39.
HakenjosLBambergMRodemannH. TGF-β1-mediated alterations of rat lung fibroblast differentiation resulting in the radiation-induced fibrotic phenotype. Int J Radiat Biol2000;76:503–9.
40.
MartinMLefaixJDelanianS. TGF-β1 and radiation fibrosis: A master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys2000;47:277–90.
41.
de GouvilleACBoullayVKrysaG. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol2005;145:166–77.
42.
MiyajimaAChenJLawrenceC. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int2000;58:2301–13.
